Nitrous Oxide Sedation: How Long Must People Really Avoid Their Normal Activities

ISRCTN ISRCTN88442975
DOI https://doi.org/10.1186/ISRCTN88442975
Secondary identifying numbers 8098
Submission date
10/05/2004
Registration date
11/05/2004
Last edited
31/08/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Lance Lichtor
Scientific

Department of Anesthesia
200 Hawkins Drive, 6 JCP
Iowa City, IA
52242
United States of America

Email lance-lichtor@uiowa.edu

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study acronymNitrous Oxide Sedation
Study objectivesNot provided at time of registration
Ethics approval(s)Provided by University Institutional Review Board.
Health condition(s) or problem(s) studiedSedation
InterventionOn three separate occasions, volunteers (N=12) received 100% oxygen or 20% or 40% N2O for 30 min. Dependent measures included the multiple sleep latency test (MSLT), a Drug Effects/Liking questionnaire, visual analogue scales, and five psychomotor tests.
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Nitrous Oxide
Primary outcome measureNot provided at time of registration
Secondary outcome measuresNot provided at time of registration
Overall study start date01/01/2003
Completion date30/06/2003

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants12
Key inclusion criteriaCandidates who stated they were healthy, non-smoking, age 21-35 years, within 30% of ideal body weight and had normal sleeping habits were scheduled for a screening interview. Urine pregnancy tests were performed to ensure that female subjects were not pregnant. Subjects were asked to avoid depressants including ethanol (confirmed by measuring exhaled ethanol) and stimulants for 24 hours before study sessions. Subjects were formally admitted to the study if, after sleep latency testing, their average sleep latency was 10 min and they had no onsets of rapid eye movement (REM) sleep, which is indicative of narcolepsy.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/01/2003
Date of final enrolment30/06/2003

Locations

Countries of recruitment

  • United States of America

Study participating centre

Department of Anesthesia
Iowa City, IA
52242
United States of America

Sponsor information

The University of Chicago (USA)
University/education

Department of Anesthesia
5841 S. Maryland Avenue
Chicago, IL
60637
United States of America

Email lance-lichtor@uiowa.edu
Website http://www.uchicago.edu/
ROR logo "ROR" https://ror.org/024mw5h28

Funders

Funder type

Research organisation

NIH (GCRC at the University of Chicago, funded by grant number M01 RR00055 from the National Center for Research Resources of the National Institutes of Health) and the Department of Anesthesia, University of Chicago

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 12/05/2004 Yes No